Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.
Psychol Med
; 53(10): 4831, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37078398
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Attention Deficit Disorder with Hyperactivity
/
Selective Serotonin Reuptake Inhibitors
Limits:
Adolescent
/
Humans
Language:
En
Journal:
Psychol Med
Year:
2023
Document type:
Article